News & Updates

Levels of the fatty acid binding protein 2 (FABP2) appear to be correlated with hot flushes in post-menopausal women, suggesting a role of intestinal barrier permeability in symptomatology, a recent study has found.

Despite widespread uptake of vaccinations, COVID-19 remains a serious health issue for high-risk patients, owing to the emergence of new variants of concern (VOCs), waning immunity, and breakthrough infections.

At a recent symposium in Singapore, esteemed experts Dr Asok Kurup, Consultant Infectious Diseases Physician at Mount Elizabeth Medical Centre, Singapore, and Dr Alex Soriano, Head of Infectious Diseases Department, Hospital Clínic of Barcelona and Assistant Professor, University of Barcelona, Spain, gave insights on the evolution of global trends since the start of the COVID-19 pandemic and discussed key challenges in managing high-risk patients with COVID-19 in the ICU. They also highlighted early treatment strategies to minimize the burden of COVID-19 on healthcare systems.

The use of ivermectin in the treatment of outpatients with mild-to-moderate COVID-19 falls short of improving time to recovery when compared with placebo, a study has shown.

Combining pembrolizumab with chemoradiation therapy (CRT) showed a trend toward improved event-free survival (EFS) compared with CRT alone in patients with locally advanced head and neck squamous cell carcinoma (HNSCC), primary results of the phase III KEYNOTE-412 trial showed.

In patients with chronic kidney disease (CKD), metabolic profiling reveals disruptions in mitochondrial energy metabolism, a new study has found.

Acute myocardial infarction patients undergoing percutaneous coronary intervention (PCI) are at heightened risk of malnutrition, which is in turn associated with increased incidence of major bleeding, all-cause death, and major ischaemic event, according to data from the COREA-AMI registries.